GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » E10

Celltrion (XKRX:068270) E10 : ₩2,708.47 (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Celltrion E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Celltrion's adjusted earnings per share data for the three months ended in Dec. 2024 was ₩1,188.810. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩2,708.47 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Celltrion's average E10 Growth Rate was 6.40% per year. During the past 3 years, the average E10 Growth Rate was 10.80% per year. During the past 5 years, the average E10 Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Celltrion was 18.10% per year. The lowest was 10.80% per year. And the median was 15.75% per year.

As of today (2025-04-06), Celltrion's current stock price is ₩173900.00. Celltrion's E10 for the quarter that ended in Dec. 2024 was ₩2,708.47. Celltrion's Shiller PE Ratio of today is 64.21.

During the past 13 years, the highest Shiller PE Ratio of Celltrion was 283.16. The lowest was 51.24. And the median was 98.62.


Celltrion E10 Historical Data

The historical data trend for Celltrion's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion E10 Chart

Celltrion Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,675.79 1,989.41 2,193.09 2,544.73 2,708.47

Celltrion Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,544.73 2,571.22 2,552.28 2,597.56 2,708.47

Competitive Comparison of Celltrion's E10

For the Biotechnology subindustry, Celltrion's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celltrion's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celltrion's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Celltrion's Shiller PE Ratio falls into.


;
;

Celltrion E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Celltrion's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1188.81/121.1352*121.1352
=1,188.810

Current CPI (Dec. 2024) = 121.1352.

Celltrion Quarterly Data

per share eps CPI Adj_EPS
201503 -98.341 99.721 -119.459
201506 382.189 100.051 462.731
201509 371.759 100.111 449.833
201512 294.144 100.220 355.528
201603 69.062 100.561 83.192
201606 371.401 100.791 446.368
201609 363.728 101.461 434.257
201612 240.835 101.561 287.251
201703 435.092 102.851 512.442
201706 735.628 102.611 868.427
201709 662.307 103.491 775.228
201712 627.483 102.991 738.030
201803 520.225 104.101 605.351
201806 515.294 104.130 599.444
201809 360.788 105.651 413.667
201812 210.638 104.351 244.518
201903 399.020 104.491 462.580
201906 482.848 104.881 557.679
201909 383.931 105.200 442.086
201912 709.350 105.121 817.410
202003 675.107 105.354 776.231
202006 887.233 105.112 1,022.484
202009 1,094.078 106.198 1,247.969
202012 732.777 105.765 839.264
202103 1,254.220 107.357 1,415.184
202106 809.811 107.579 911.860
202109 874.452 108.759 973.958
202112 853.641 109.676 942.828
202203 750.916 111.848 813.268
202206 1,166.667 114.072 1,238.902
202209 1,063.187 114.715 1,122.687
202212 579.158 115.179 609.107
202303 1,100.000 116.507 1,143.693
202306 984.762 117.182 1,017.983
202309 1,486.667 118.964 1,513.805
202312 8.571 118.837 8.737
202403 102.857 120.123 103.724
202406 359.048 120.007 362.423
202409 394.286 120.861 395.180
202412 1,188.810 121.135 1,188.810

Add all the adjusted EPS together and divide 10 will get our e10.


Celltrion  (XKRX:068270) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Celltrion's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=173900.00/2708.47
=64.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Celltrion was 283.16. The lowest was 51.24. And the median was 98.62.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Celltrion E10 Related Terms

Thank you for viewing the detailed overview of Celltrion's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Celltrion Business Description

Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion Headlines

No Headlines